Pharmacy Group Journals’ Post

Follow our page to keep up with the latest updates and news.

Introducing heuling pharmaceuticals!

News!!! We've just refreshed our PRES (Pharmaceutical Resource & Education Services) page on LinkedIn!

I enjoyed a recent panel discussion on the future of generics and biosimilars at the recent Medicines for Europe Annual conference in Dublin. Some interesting points came through, especially from Rebecca Guntern, Sandoz CCO and Stephan Eder, EVP Western Europe & Germany at STADA: In short - the industry has all the data it needs to address the challenges we face. What’s needed now is immediate action—especially when it comes to pricing reform and regulatory changes. Pricing structure that incorporates factors such as security of supply, quality, and environmental impact, rather than solely focusing on cost reduction An holistic view must be sought: The need to view healthcare system in its entirety, and the fact that the pharmaceutical sector, whilst a significant factor, cannot shoulder all the cost-cutting pressures alone. This, combined with the importance of collaboration among pharmaceutical companies, even competitors, to share resources, co-develop products, and streamline procurement and distribution...   Listen to the complete webinar here: https://lnkd.in/ePY_pMKk    

Here's the latest from IPWatchdog! Check it out!

Anticipate and overcome roadblocks. Watch this webinar on-demand now to discover how the power of technological expertise and innovative resources can help you adapt and pivot quickly. https://okt.to/WmYp9c

Please see my latest article

Anticipate and overcome roadblocks. Watch this webinar on-demand now to discover how the power of technological expertise and innovative resources can help you adapt and pivot quickly. https://okt.to/SjqTaW

Anticipate and overcome roadblocks. Watch this webinar on-demand now to discover how the power of technological expertise and innovative resources can help you adapt and pivot quickly. https://okt.to/TJLPDj

Heading to the 𝟏𝟗𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐂𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 in San Diego, the #USA? Don't miss the chance to connect with Tejas Upadhyay from our team! Tejas, our VP of Business Development, will be on the ground, ready to discuss how our expertise in drug discovery services can support your project. From integrated solutions to tailored strategies, we've got you covered every step of the way. Schedule a meeting now by clicking on the link: https://lnkd.in/djEhaW35 At o2h discovery, we've in-house capabilities across chemistry and biology to support integrated drug discovery and development projects for our collaborators. Specializing in the synthesis, optimization, and screening of drug candidates across various therapeutic areas, we offer expertise in specialized modalities such as PROTACs, peptides, and Lipids synthesis for Lipid Nanoparticles, ensuring a comprehensive approach to addressing diverse research needs. For more information, write us at discovery@o2h.com Let's connect and explore possibilities! #DrugDiscoveryChemistry #drugdiscovery #drugdevelopment  #smallmolecule #PROTAC #FBDD #colloborativeinnovation #synthesis #screening #optimization